Quality key factors
Factor
Value
Sales Growth (5y)
9.99%
EBIT Growth (5y)
3.42%
EBIT to Interest (avg)
-57.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.28
Sales to Capital Employed (avg)
0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
11.90
EV to EBIT
-1.89
EV to EBITDA
-2.11
EV to Capital Employed
-16.49
EV to Sales
182.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-827.60%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Movement
11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -96.7 MM
NET SALES(HY)
At SEK 0.59 MM has Grown at 90.38%
NET PROFIT(HY)
Higher at SEK -54.72 MM
RAW MATERIAL COST(Y)
Fallen by -17.54% (YoY
OPERATING PROFIT(Q)
Highest at SEK -17.17 MM
-21What is not working for the Company
ROCE(HY)
Lowest at -360.19%
CASH AND EQV(HY)
Lowest at SEK 62.99 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 0%
INTEREST(Q)
Highest at SEK 38.91 MM
PRE-TAX PROFIT(Q)
Lowest at SEK -57.79 MM
NET PROFIT(Q)
Lowest at SEK -57.79 MM
Here's what is working for Immunovia AB
Net Sales
At SEK 0.59 MM has Grown at 90.38%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (SEK MM)
Operating Cash Flow
Highest at SEK -96.7 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Operating Profit
Highest at SEK -17.17 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SEK MM)
Raw Material Cost
Fallen by -17.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Immunovia AB
Pre-Tax Profit
At SEK -57.79 MM has Fallen at -202.02%
over average net sales of the previous four periods of SEK -19.14 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -57.79 MM has Fallen at -202.02%
over average net sales of the previous four periods of SEK -19.14 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Interest
At SEK 38.91 MM has Grown at 228,794.12%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Interest
Highest at SEK 38.91 MM
in the last five periods and Increased by 228,794.12% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Pre-Tax Profit
Lowest at SEK -57.79 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (SEK MM)
Net Profit
Lowest at SEK -57.79 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (SEK MM)
Cash and Eqv
Lowest at SEK 62.99 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 0%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






